Neuroblastoma trials in Lithuania

2 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

• Phase 2Taking people
  177Lutetium-DOTATATE in Children With Primary Refractory or Relapsed High-risk Neuroblastoma

  Where

  Vilnius

  Age

  18 months to 64 years

  People

  24 worldwide

  Run by

  Jakob Stenman

  See details and how to joinNCT04903899 · EU 2023-503684-42-00
• Phase 3Taking people
  High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)

  Where

  Vilnius

  Age

  Up to 21 years

  People

  800 worldwide

  Run by

  Gustave Roussy, Cancer Campus, Grand Paris

  See details and how to joinNCT04221035 · EU 2024-514917-36-00